The availability of 750mcg teriparatide injection in Australia has experienced modest sales . Currently, it’s primarily administered for patients with severe osteoporosis who other treatments have proven inadequate . Securing this more potent formulation presents as difficult due to physician approval requirements and limited clinic supply . Desp